Medicare may expand coverage for GLP-1 drugs like Wegovy in 2026. Learn who may qualify, what the program includes, and how ...

President Trump announced the popular GLP-1 weight loss drugs would soon be more accessible to millions of Americans at a ...

With updates to the FEHB program and new requirements for certain retirees, it’s more important than ever to understand how FEHB and Medicare work together.

Starting July 2026, Medicare will pilot the 'GLP-1 Bridge,' a temporary program allowing some retirees coverage for weight loss drugs like Wegovy and Zepbound. The initiative marks a shift from ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.

Americans enrolled in Medicare Advantage health plans should expect to see fewer extra benefits like gym memberships and ...

Medicare limits access to lifesaving treatments for common illnesses, including a type of heart valve disease affecting 2.5 ...

Many older Americans look at Medicare as a safety net, like Social Security. But while both programs can change from year to ...

Your initial Medicare enrollment window starts three months before the month you turn 65 and ends three months after that ...